Omni Peptides
IPA/CJC Blend
Couldn't load pickup availability
CJC-1295 No DAC + Ipamorelin (often called the “Gold Standard” GH-releasing combo or CJC/Ipa blend) is a synthetic peptide combination pairing CJC-1295 without DAC (Modified GRF 1-29) with Ipamorelin, typically provided in a single lyophilized vial (common ratios include 5 mg CJC-1295 No DAC + 5 mg Ipamorelin, 2 mg/2 mg, or 10 mg total blends). This research formulation has become one of the most widely studied and utilized growth hormone secretagogue stacks in preclinical models due to its potent synergistic stimulation of endogenous pulsatile growth hormone (GH) release while maintaining a remarkably clean side-effect profile. CJC-1295 No DAC acts as a GHRH analog to amplify GH pulse amplitude, while Ipamorelin functions as a selective ghrelin mimetic (GHS-R1a agonist) to increase pulse frequency and potency, resulting in supra-additive GH/IGF-1 elevation. Researchers employ this blend in laboratory and animal models to investigate mechanisms of GH axis physiology, body composition optimization, tissue repair, metabolic regulation, and age-related endocrine decline. As a research-grade compound, CJC-1295 No DAC + Ipamorelin is intended exclusively for in vitro and animal studies. Scientists value its near-physiological pulsatile GH pattern, minimal impact on cortisol/prolactin, lack of significant appetite stimulation, and exceptional synergy for studying maximal endogenous GH output without exogenous hormone administration.
Research Applications
Storage & Handling
Storage & Handling
Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Beyond Use Date
Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.
— About this compound
IPA/CJC Blend is a combined GHRP/GHRH peptide blend.
CJC-1295 No DAC + Ipamorelin (often called the “Gold Standard” GH-releasing combo or CJC/Ipa blend) is a synthetic peptide combination pairing CJC-1295 without DAC (Modified GRF 1-29) with Ipamorelin, typically provided in a single lyophilized vial (common ratios include 5 mg CJC-1295 No DAC + 5 mg Ipamorelin, 2 mg/2 mg, or 10 mg total blends). This research formulation has become one of the most widely studied and utilized growth hormone secretagogue stacks in preclinical models due to its potent synergistic stimulation of endogenous pulsatile growth hormone (GH) release while maintaining a remarkably clean side-effect profile. CJC-1295 No DAC acts as a GHRH analog to amplify GH pulse amplitude, while Ipamorelin functions as a selective ghrelin mimetic (GHS-R1a agonist) to increase pulse frequency and potency, resulting in supra-additive GH/IGF-1 elevation. Researchers employ this blend in laboratory and animal models to investigate mechanisms of GH axis physiology, body composition optimization, tissue repair, metabolic regulation, and age-related endocrine decline. As a research-grade compound, CJC-1295 No DAC + Ipamorelin is intended exclusively for in vitro and animal studies. Scientists value its near-physiological pulsatile GH pattern, minimal impact on cortisol/prolactin, lack of significant appetite stimulation, and exceptional synergy for studying maximal endogenous GH output without exogenous hormone administration.
Two compounds, one formulation.
CJC-1295 No DACC₁₅₂H₂₅₂N₄₄O₄₂
3367.9 g/mol
▾
IpamorelinC₃₈H₄₉N₉O₅
711.85 g/mol
▾
Research Applications
Where researchers apply it.
— Verified & Documented
Every vial is backed by a Certificate of Analysis.
Each lot is independently characterised by HPLC and mass spectrometry, with identity, mass and purity documented per batch and available on request.
Additional quality-control testing, including sterility, endotoxin and heavy metals, is conducted periodically across our product range.
Storage & Handling
Storage & Handling
Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Beyond Use Date
Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.